LIPRIDIA Trademark

Trademark Overview

On Friday, July 24, 2020, a trademark application was filed for LIPRIDIA with the United States Patent and Trademark Office. The USPTO has given the LIPRIDIA trademark a serial number of 90072227. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 11, 2024. This trademark is owned by Cadila Healthcare Limited. The LIPRIDIA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of Diabetes, Dyslipidemia, NASH, Hypertriglycedemia and HIV-induced lipodystrophy
lipridia

General Information

Serial Number90072227
Word MarkLIPRIDIA
Filing DateFriday, July 24, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 11, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of Diabetes, Dyslipidemia, NASH, Hypertriglycedemia and HIV-induced lipodystrophy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 21, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCadila Healthcare Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressGujarat 382481
IN
Party NameCadila Healthcare Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressGujarat 382481
IN

Trademark Events

Event DateEvent Description
Monday, March 11, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, March 11, 2024ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 15, 2023SOU EXTENSION 5 GRANTED
Tuesday, August 8, 2023SOU EXTENSION 5 FILED
Tuesday, August 15, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, August 8, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, February 8, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 6, 2023SOU EXTENSION 4 GRANTED
Monday, February 6, 2023SOU EXTENSION 4 FILED
Monday, February 6, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 9, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 5, 2022SOU EXTENSION 3 GRANTED
Friday, August 5, 2022SOU EXTENSION 3 FILED
Friday, August 5, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, February 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 4, 2022SOU EXTENSION 2 GRANTED
Friday, February 4, 2022SOU EXTENSION 2 FILED
Friday, February 4, 2022SOU TEAS EXTENSION RECEIVED
Thursday, July 29, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, July 27, 2021SOU EXTENSION 1 GRANTED
Tuesday, July 27, 2021SOU EXTENSION 1 FILED
Tuesday, July 27, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, February 9, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, November 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, November 12, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 10, 2020ASSIGNED TO EXAMINER
Friday, August 21, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 28, 2020NEW APPLICATION ENTERED

Related Keywords

lipridia hypertriglycedemia induced lipodystrophy nash dyslipidemia preparations treatment diabetes pharmaceutical